Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens

International Journal of Pharmaceutics

Volumn 242, Issue 1-2, 2002, Pages 15-24

  Fattal, Elias ^a   Pecquet, Sophie ^b   Couvreur, Patrick ^a   Andremont, Antoine ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Microparticles; Mucosal immunity; Oral tolerance; Phosphorylcholine; Poly(lactide co glycolide)

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTOGLOBULIN; FOOD ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; PHOSPHORYLCHOLINE; POLYGLACTIN;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTESTINE INFECTION; INTESTINE SECRETION; LUNG INFECTION; MICROENCAPSULATION; MILK ALLERGY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGENS; COLONY COUNT, MICROBIAL; EXCIPIENTS; FEMALE; FOOD HYPERSENSITIVITY; IMMUNOGLOBULINS; LACTIC ACID; LACTOGLOBULINS; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; PNEUMOCOCCAL INFECTIONS; POLYGLYCOLIC ACID; POLYMERS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE;

EID: 0037151466     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00181-3     Document Type: Article

References (40)

1. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres
2. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres
3. Nasal delivery of vaccines
4. Polymeric carriers for oral uptake of microparticulates
5. Phosphorus assay in column chromatography
6. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae
7. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
8. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles
9. Systemic tolerance and secretory immunity after oral immunization
10. Competitive adsorption of b lactoglobulin and Tween 20 at the oil-water interface
11. A method for quantifying particle absorption from the small intestine of the mouse
12. Controlled vaccine release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyers patches
13. Biodegradable microspheres as a vaccine delivery system
14. Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance
15. Breaking of oral tolerance by encapsulated antigen
16. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
17. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients
18. Aspects of the design and delivery of microparticles for vaccine applications
19. Milk protein enteropathy after acute infectious gastroenteritis: Experimental and clinical observations
20. The role of nasopharyngeal lymphoid tissue
21. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method
22. Cross-reactive antibodies have both protective and pathogenic potential
23. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia
24. New perspectives in vaccine development: Mucosal immunity to infections
25. The common mucosal immune system and current strategies for the induction of immune responses in external secretions
26. The intestinal uptake of particles and the implications for drug and antigen delivery
27. Enhancement of mucosal antibody responses to Salmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity
28. Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to beta-lactoglobulin
29. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease
30. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA
31. A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres
32. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit
33. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection
34. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres
35. Dietary manipulation and induction of tolerance
36. Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b
37. Towards a multipurpose vaccination using phosphorylcholine as a unique antigen
38. In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin
39. Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with Streptococcus pneumoniae
40. Pneumococcal virulence factors and host immune responses to them